Viewing Study NCT04657874



Ignite Creation Date: 2024-05-06 @ 3:30 PM
Last Modification Date: 2024-10-26 @ 1:51 PM
Study NCT ID: NCT04657874
Status: COMPLETED
Last Update Posted: 2021-09-13
First Post: 2020-12-01

Brief Title: Bromelain and Escin in the Reduction of Postoperative Sequelae in Periodontal and Implant Surgery
Sponsor: University of LAquila
Organization: University of LAquila

Study Overview

Official Title: Association Between Bromelain and Escin in the Reduction of Postoperative Sequelae in Periodontal and Implant Surgery Randomized Clinical Trial Placebo-controlled Double-blind
Status: COMPLETED
Status Verified Date: 2021-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: A randomized clinical trial will be performed in parallel placebo controlled triple-blind to evaluate the effectiveness of the association Bromelina and Horse-chestnut titrated in escin Noflogo Mavenpharma srl Rome Italy in the management of post trauma-surgery following surgery periodontal and implant surgery
Detailed Description: At least 50 volunteers between the ages of 18 and 50 will be enlisted with the need to perform one of the interventions described above and that fall within the criteria of inclusion

The study will be carried out in accordance with the Helsinki Declaration on In Vivo Studies and will be initiated with the approval of the Internal Review Board of the University of LAquila

The protocol follows the guidelines of the CONSORT Statement for parallel studies and will be recorded on the data base clinicaltrialsgov

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: None